Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.*
1349
(1) 2021
(2) A
5 43
44 45
46 70
339
*
........................................................... 1
...................................................... 5
.............................................. 44
................................................ 46
........................ I-1
............... II-1
................................................ III-1
–i–
A 0.1
A
A
H
H
A H
H
01349 A
688505
–1–
3,284
86.42%
H 0.1
–2–
571 6
516
13.58%
A
–3–
0.1
H A
3,800 A
%
*
–4–
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.*
1349
308
201210
8
19
(1) 2021
(2) A
A
(i) (ii) (iii)
–5–
A
A
I.
II.
A
III.
3,800
104,300 3.64% 3,284
3.15%
86.42% 516 0.49%
13.58%
20.00%
1.00%
–6–
IV.
A.
1.
4
2.
B.
266
628 42.36%
–7–
C.
1.
2.
3.
4.
5.
6.
–8–
D.
100 2.63% 0.10%
120 3.16% 0.12%
120 3.16% 0.12%
110 2.89% 0.11%
120 3.16% 0.12%
120 3.16% 0.12%
110 2.89% 0.11%
100 2.63% 0.10%
70 1.84% 0.07%
30 0.79% 0.03%
40 1.05% 0.04%
1,040 27.37% 1.00%
255 * 2,244 59.05% 2.15%
3,284 86.42% 3.15%
516 13.58% 0.49%
3,800 100.00% 3.64%
* 255
–9–
20.00%
V.
A.
A 8.95
A
A 8.95
B.
1.
8.95 A
2021 4 6
H 4.390 203.87%
A 14.55 38.49%
2021 4 6 20 H
4.397 203.55% A
14.81 20
39.57%
– 10 –
2021 4 6 60 H
4.544 196.96% A
16.19 60
44.72%
2021 4 6 120 H
4.255 210.34% A
18.60 60
51.88%
2.
a)
50% b)
20 60 120 50%
– 11 –
8.95 A
VI.
A.
B.
– 12 –
C.
30%
30%
40%
– 13 –
50%
50%
D.
1.
25%
2.
– 14 –
3.
VII.
A.
1.
a.
b.
c.
d.
e.
– 15 –
2.
a.
b.
c.
d.
e.
f.
B.
1.
a.
b.
c.
d.
e.
– 16 –
2.
a.
b.
c.
d.
e.
f.
3.
– 17 –
A B C
100% 80% 60%
1 2021 1 2021 1 2021
10.4 10 10
2 2021 2 2021 2 2021
4 4 3
1 2021-2022 1 2021-2022 1 2021-2022
23.9 22.5 22
2 2021-2022 2 2021-2022 2 2021-2022
9 8 7
– 18 –
A B C
100% 80% 60%
1 2021-2023 1 2021-2023 1 2021-2023
41.5 38.1 36.4
2 2021-2023 2 2021-2023 2 2021-2023
14 12 11
– 19 –
A B C
100% 80% 60%
1 2021-2022 1 2021-2022 1 2021-2022
23.9 22.5 22
2 2021-2022 2 2021-2022 2 2021-2022
9 8 7
1 2021-2023 1 2021-2023 1 2021-2023
41.5 38.1 36.4
2 2021-2023 2 2021-2023 2 2021-2023
14 12 11
– 20 –
4.
100% 80% 60% 0
C
5.
– 21 –
VIII.
A.
1.
2.
3.
4.
– 22 –
5.
6.
7.
8.
9.
10.
B.
1.
– 23 –
2.
3.
4.
5.
– 24 –
6.
7.
C.
1.
2.
3.
– 25 –
IX.
A.
1.
Q Q0 (1 n)
Q0 n
Q
2.
Q Q0 P1 (1 n) (P1 P2 n)
Q0 P1 P2
n
Q
3.
Q Q0 n
Q0 n 1
n Q
4.
– 26 –
B.
1.
P P0 (1 n)
P0 n
P
2.
P P0 (P1 P2 n) [P1 (1 n)]
P0 P1 P2
n P
3.
P P0 n
P0 n P
4.
P P0-V
P0 V P
P 0.1
5.
– 27 –
C.
X.
A.
1.
2.
3.
4.
5.
– 28 –
6.
7.
B.
1.
2.
3.
4.
5.
6.
7.
– 29 –
8.
9.
C.
XI.
A.
– 30 –
B.
C.
1.
a.
b.
c.
d.
e.
2.
– 31 –
3.
4.
D.
1.
a.
b.
c.
– 32 –
2.
a.
b.
3.
4.
a.
b.
5.
a.
– 33 –
b.
6.
7.
a.
b.
c.
d.
e.
f.
8.
– 34 –
XII.
A.
11 22
=
B.
3,800 3,284
A
18,751.64
2021 2022 2023 2024
18,751.64 5,469.23 8,125.71 3,906.59 1,250.11
– 35 –
A
3,800
(i) 3,284
266
3.15% (ii) 516
0.49%
460 4
2,824 262
IV. D.
A
34,010
3,800
A 8.95
V.
A
A A 0.10
380
12
– 36 –
97,432.39 1.
A
2.
3.
1.
(1)
(2)
(3)
(4)
– 37 –
(5)
(6)
(7)
(8)
(9)
(10)
(11)
(12)
2.
– 38 –
3.
4.
– 39 –
H
1349 A 688505
17
14A
14A
– 40 –
H A
339 H
(http://www.hkexnews.hk) (www.fd-zj.com)
www.hkex.com.hk
H
24 H 183
17M
H
A
H
H H
H H
H
– 41 –
H H
H
H
H 183 17 1712-1716
(1) 57,886,430 A
5.55% 11 13
2 4
(2) 22,312,860 A
2.14% 11 13
2 4
(3) 19,260,710 A
1.85% 11 13
2 4
(i)
(ii)
– 42 –
– 43 –
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.*
1349
A
– 44 –
– 45 –
A
A
38,000,000
3.64%, 32,840,000
5,160,000
4,600,000 4
– 46 –
14A
14A
13.84
– 47 –
1.
– 48 –
A
833.8 1,029.3 741.8
(139.3) (127.8) (114.3)
(50.8) (54.9) (83.6)
(426.9) (530.6) (399.6)
173.0 247.5 93.0
164.7 227.4 112.1
– 49 –
2.
4 4,600,000
1,000,000 2.63% 0.10%
1,200,000 3.16% 0.12%
1,200,000 3.16% 0.12%
1,200,000 3.16% 0.12%
4,600,000 12.11% 0.46%
A 8.95
A
(i)
– 50 –
H 4.390 203.87%
A 14.55 38.49%
(ii) 20
H 4.397 203.55%
A 14.81 39.57%
(iii) 60
H 4.544 196.96%
A 16.19 44.72%
(iv) 120
H 4.255 210.34%
A 18.60 51.88%
48
– 51 –
30%
30%
40%
50%
50%
– 52 –
(i)
(ii)
3.
4
600226
– 53 –
20
– 54 –
4.
(i)
(ii) 5.
A
(iii)
– 55 –
5.
5.1 A
A (a)
(b)
A A
(i)
A (ii)
A
– 56 –
A
A A
20 60 120
2021 3 31 25.00 20.43 36 65.35% 65.58% 67.17% 61.09% 50%: 12 24 0.91%
(688321.SH) 50%: 24 36
2021 3 31 10.00 14.41 48 51.47% 48.71% 43.65% 36.39% 30%: 12 24 2.00%
(688556.SH) 30%: 24 36
40%: 36 48
2021 3 31 80.00 47.20 36 45.70% 48.94% 40.94% 48.43% 50%: 12 24 1.25%
(688598.SH) 50%: 24 36
2021 3 27 17.50 17.50 60 80.94% 75.46% 83.77% 84.92% 40%: 12 24 4.09%
18.50
(688007.SH) 21.00 30%: 24 36
30%: 36 48
2021 3 27 30.00 16.49 96 50.81% 41.91% 46.38% 46.88% 30%: 12 24 1.00%
(688026.SH) 30%: 24 36
40%: 36 48
2021 3 26 15.65 21.59 60 64.49% 65.09% 64.06% 55.31% 30%:12 24 3.53%
(688078.SH) 30%:24 36
40%: 36 48
2021 3 26 42.76 15.53 48 50.00% 54.72% 56.23% 57.84% 50%:12 24 0.63%
(688139.SH) 30%: 24 36
20%: 36 48
– 57 –
A
A A
20 60 120
2021 3 25 22.79 20.35 48 97.01% 98.19% 92.21% 74.52% 40%:12 24 6.99%
(688159.SH) 30%: 24 36
30%: 36 48
2021 3 16 9.00 14.34 60 55.78% 54.52% 52.60% 43.40% 30%: 12 24 3.26%
(688096.SH) 30%: 24 36
40%: 36 48
2021 3 15 25.01 62.57 60 50.01% 50.85% 47.68% 39.04% 20%: 12 24 1.32%
(688378. 40%: 24 36
SH)
40%: 36 48
2021 3 4 35.83 33.23 72 81.01% 82.90% 83.19% 70.41% 50%: 24 36 4.91%
(688158.SH) 25%: 36 48
25%: 48 60
2021 3 2 21.00 26.90 60 50.00% 50.00% 50.00% 50.00% 30%: 12 24 4.87%
(688118.SH) 30%: 24 36
40%: 36 48
96 97.01% 98.19% 92.21% 84.92% 6.99%
36 45.70% 41.91% 40.94% 36.39% 0.63%
57 61.88% 61.41% 60.66% 55.69% 2.90%
60 53.63% 54.62% 54.42% 52.66% 2.63%
2021 4 6 48 61.51% 60.43% 55.28% 48.12% 30%: 12 24 3.64%
30%: 24 36
40%: 36 48
A
– 58 –
48
(a)
41.5
14 (b) 14
(a)
8.338
10.3 2.356 (b)
12
4 2 (c)
3
(a)
(b)
– 59 –
A 8.95
(a) A A 14.55
61.51%
(b) 20 A A
14.81 60.43%
(c) 60 A A
16.19 55.28%
(d) 120 A A
18.60 48.12%
10 10.6
(a)
50% (b) 20 60 120
50%
(a) A
45.70% 97.01% 61.88%
53.63%
– 60 –
(b) 20 A
41.91% 98.19% 61.41%
54.62%
(c) 60 A
40.94% 92.21% 60.66%
54.42%
(d) 120 A
36.39% 84.92% 55.69%
52.66%
(e)
A
(a)
(b)
(c)
(d) H 20 60 120
H
(e) A
– 61 –
12
48
30% 30% 40%
A
12 24 36 48 60
20%
– 62 –
1%
38,000,000 A
3.64%
(a)
(b)
(i) (c)
(d)
(e)
0.12%
5.2
(a)
(b)
(c)
– 63 –
5.2
S&P
Capital IQ (i)
(ii) (iii)
– 64 –
1
656 9,560,000
26,312,000
1061 580,124
2,372,747
2
1358 1,039,000
1530 1,072,000
3,347,000
1801 8,926,000
75,664,000
1877 3,434,000
7,472,000
1952 4,618,000
5,980,000
2142 2,298,348
4,072,856
3
2181 1,432,000
5,949,000
2269 5,622,000
25,196,000
2696 3,939,000
6600 14,527,000
6978 664,000
904,000
6996 1,133,000
3,573,000
6998 15,923,000
8049 218,000
515,000
9688
9926 1,792,000
2,321,000
– 65 –
1
9939 2,278,000
9966 7,203,000
48,152,000
9995 562,000
744,000
1349 2,428,000
3,276,000
4
1.
2. 1 1.1865
3. 1 6.5480
4.
20 7,570 21
9 9
20
500
– 66 –
5.3
(a)
(b)
(c) A
(d)
(e) A 20 60 120 A
(f) H 20 60 120 H
(g)
(h)
– 67 –
6.
(i)
XII.
32,840,000
A
18,752
A
38,000,000 (a)
A 14.66 (b) A
8.95 38,000,000
21,698
12,980
15.6%
(a) 41.5
(b)
12,980
(c)
60,637 12,980
– 68 –
14.6%
15.6%
(a) 4 (b)
A
A
(i)
13.969
(a) A
8.95 (b) 38,000,000
3.401
– 69 –
6
6
– 70 –
2021
2021
2021
4
A
A
3,800
104,300 3.64%
3,284 3.15%
– I-1 –
2021
86.42% 516
0.49%
13.58%
20.00%
1.00%
266
12
8.95
48
– I-2 –
2021
12
30% 30% 40% 12
50% 50%
A B C
100% 80% 60%
1 2021 1 2021 1 2021
10.4 10 10
2 2021 2 2021 2 2021
4 4 3
– I-3 –
2021
A B C
100% 80% 60%
1 2021- 1 2021- 1 2021-
2022 2022 2022
23.9 22.5 22
2 2021- 2 2021- 2 2021-
2022 2022 2022
9 8 7
1 2021- 1 2021- 1 2021-
2023 2023 2023
41.5 38.1 36.4
2 2021- 2 2021- 2 2021-
2023 2023 2023
14 12 11
– I-4 –
2021
A B C
100% 80% 60%
1 2021- 1 2021- 1 2021-
2022 2022 2022
23.9 22.5 22
2 2021- 2 2021- 2 2021-
2022 2022 2022
9 8 7
1 2021- 1 2021- 1 2021-
2023 2023 2023
41.5 38.1 36.4
2 2021- 2 2021- 2 2021-
2023 2023 2023
14 12 11
– I-5 –
2021
36
12
12
12
– I-6 –
2021
60
60
60
– I-7 –
2021
........................................................... I-1
........................................................ I-1
.................................................... I-9
......................................... I-11
..................................... I-12
................................. I-13
............................... I-16
.......................... I-17
.......................... I-19
............................ I-22
............................... I-24
............................... I-31
................................... I-34
............... I-36
............................ I-40
................ I-43
.................................................. I-47
– I-8 –
2021
2021
– I-9 –
2021
4
2021
– I-10 –
2021
– I-11 –
2021
– I-12 –
2021
266
628 42.36%
1
2
3
5%
– I-13 –
2021
12
12
12
12
12
10
– I-14 –
2021
5
– I-15 –
2021
A
3,800
104,300 3.64% 3,284
3.15%
86.42% 516 0.49%
13.58%
20.00%
1.00%
– I-16 –
2021
100 2.63% 0.10%
120 3.16% 0.12%
120 3.16% 0.12%
110 2.89% 0.11%
120 3.16% 0.12%
120 3.16% 0.12%
110 2.89% 0.11%
100 2.63% 0.10%
70 1.84% 0.07%
30 0.79% 0.03%
40 1.05% 0.04%
1,040 27.37% 1.00%
255 2,244 59.05% 2.15%
3,284 86.42% 3.15%
516 13.58% 0.49%
3,800 100.00% 3.64%
– I-17 –
2021
1
1.00%
20.00%
20.00%
2
3 12
– I-18 –
2021
48
60
60
60
12
60
30
10
– I-19 –
2021
2
12 30%
24
24 30%
36
36 40%
48
12 50%
24
24 50%
36
– I-20 –
2021
25%
6 6
– I-21 –
2021
8.95
8.95
8.95
8.95
1 14.55
1 61.53%
20 14.81
20 60.45%
60 16.19
60 55.27%
120 18.60
120 48.13%
– I-22 –
2021
8.95
(www.sse.com.cn)
2021
10.6
– I-23 –
2021
1
2
3 36
4
5
1 12
2 12
3 12
4
5
6
– I-24 –
2021
1
2
3 36
4
5
1 12
2 12
3 12
4
5
6
– I-25 –
2021
12
2021 2023
A B C
100% 80% 60%
1 2021 1 2021 1 2021
10.4 10 10
2 2021 2 2021 2 2021
4 4 3
– I-26 –
2021
A B C
100% 80% 60%
1 2021- 1 2021- 1 2021-
2022 2022 2022
23.9 22.5 22
2 2021- 2 2021- 2 2021-
2022 2022 2022
9 8 7
1 2021- 1 2021- 1 2021-
2023 2023 2023
41.5 38.1 36.4
2 2021- 2 2021- 2 2021-
2023 2023 2023
14 12 11
– I-27 –
2021
A B C
100% 80% 60%
1 2021- 1 2021- 1 2021-
2022 2022 2022
23.9 22.5 22
2 2021- 2 2021- 2 2021-
2022 2022 2022
9 8 7
1 2021- 1 2021- 1 2021-
2023 2023 2023
41.5 38.1 36.4
2 2021- 2 2021- 2 2021-
2023 2023 2023
14 12 11
– I-28 –
2021
C
100% 80% 60% 0
C
=
3
10
– I-29 –
2021
– I-30 –
2021
Q Q0 (1 n)
Q0 n
Q
Q Q0 P1 (1 n)/(P1 P2 n)
Q0 P1 P2
n Q
Q Q0 n
Q0 n 1 n
Q
– I-31 –
2021
P P0 (1 n)
P0 n
P
P P0 (P1 P2 n)/[P1 (1 n)]
P0 P1 P2
n P
P P0 n
P0 n P
P P0–V
P0 V P
P 0.1
– I-32 –
2021
– I-33 –
2021
11 22
11 22
=
3,800 3,284
18,751.64
2021 6
2021 2024
2021 2022 2023 2024
18,751.64 5,469.23 8,125.71 3,906.59 1,250.11
– I-34 –
2021
1
2
3
– I-35 –
2021
2
6
10
5
– I-36 –
2021
60
60
– I-37 –
2021
60
60
3
12
12
– I-38 –
2021
1
2
1
2
– I-39 –
2021
– I-40 –
2021
– I-41 –
2021
– I-42 –
2021
1
2
3 36
4
5
5
5
– I-43 –
2021
1
2
3
1
– I-44 –
2021
2
1
2
1
2
– I-45 –
2021
1 12
2 12
3 12
4
5
6
– I-46 –
2021
– I-47 –
2021
2021
2021
– II-1 –
– II-2 –
2021 2023
A B C
100% 80% 60%
1 2021 1 2021 1 2021
10.4 10 10
2 2021 2 2021 2 2021
4 4 3
– II-3 –
A B C
100% 80% 60%
1 2021- 1 2021- 1 2021-
2022 2022 2022
23.9 22.5 22
2 2021- 2 2021- 2 2021-
2022 2022 2022
9 8 7
1 2021- 1 2021- 1 2021-
2023 2023 2023
41.5 38.1 36.4
2 2021- 2 2021- 2 2021-
2023 2023 2023
14 12 11
– II-4 –
A B C
100% 80% 60%
1 2021- 1 2021- 1 2021-
2022 2022 2022
23.9 22.5 22
2 2021- 2 2021- 2 2021-
2022 2022 2022
9 8 7
1 2021- 1 2021- 1 2021-
2023 2023 2023
41.5 38.1 36.4
2 2021- 2 2021- 2 2021-
2023 2023 2023
14 12 11
– II-5 –
100% 80% 60% 0
C
=
2021 2023
– II-6 –
1 5
2
10
3
1
2
3 10
– II-7 –
– II-8 –
1.
2.
XV 7 8
352
A 5,888.06(L) 8.38% 5.65%
A 2,310.89(L) 3.29% 2.22%
A 2,005.68(L) 2.85% 1.92%
A 140.87(L) 0.20% 0.14%
A 109.84(L) 0.16% 0.11%
1. L
2. A
– III-1 –
99.42 79.61
79.61 23.87 29.84 A
XV
352
XV 2 3
336
A 139,578,560 (L) 19.85%
20.15%
H 70,564,000 (L) 20.75%
A 139,578,560 (L) 19.85%
20.15%
H 70,564,000 (L) 20.75%
A 156,892,912 (L) 22.32% 15.04%
A 80,000,000 (L) 11.38% 7.67%
Investco HongKong
H 30,835,000 (L) 9.07% 2.96%
Limited
L
XV
2 3 336
– III-2 –
3.
4.
(a)
(b)
5.
6.
7.
– III-3 –
8.
6
(a)
(b)
9.
(a) 308
201210
(b) 8 19
(c) H
183 17M
(d)
– III-4 –
(e)
(f)
10.
14
8
19
(a) 44 45
(b) 46 70
(c)
(d)
(e)
– III-5 –